Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mattson

Showing results (161-170 of 190) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapyF A Shepherd, J Dancey, R Ramlau, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1997
Concurrent treatments and induction treatments for unresectable tumorsJ Klastersky, M Cullen, B Sause, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2016
Synthesis and evaluation of carbamate and aryl ether substituted pyrazinones as corticotropin releasing factor-1 (CRF₁) receptor antagonistsVijay T Ahuja, Richard A Hartz, Thaddeus F Molski, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2011
Mechanical stochastic tug-of-war models cannot explain bidirectional lipid-droplet transportAmbarish Kunwar, Suvranta K Tripathy, Jing Xu, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practiceK Mattson, L Bosquee, G Dabouis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancerU Gatzemeier, J von Pawel, M Gottfried, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancerA B Sandler, J Nemunaitis, C Denham, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 23, 1999
Concomitant chemotherapy and IFN-alpha for small cell lung cancer: a randomized multicenter phase III studyT M Ruotsalainen, M Halme, K Tamminen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II studyU Gatzemeier, F A Shepherd, T Le Chevalier, et al.
Bulletin Du Cancer|March 1, 1997
[A phase II multicenter study of gemcitabine in non small cell lung cancers]T Le Chevalier, M Gottfried, U Gatzemeier, et al.
Pageof 19

Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapyF A Shepherd, J Dancey, R Ramlau, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1997
Concurrent treatments and induction treatments for unresectable tumorsJ Klastersky, M Cullen, B Sause, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2016
Synthesis and evaluation of carbamate and aryl ether substituted pyrazinones as corticotropin releasing factor-1 (CRF₁) receptor antagonistsVijay T Ahuja, Richard A Hartz, Thaddeus F Molski, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2011
Mechanical stochastic tug-of-war models cannot explain bidirectional lipid-droplet transportAmbarish Kunwar, Suvranta K Tripathy, Jing Xu, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practiceK Mattson, L Bosquee, G Dabouis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancerU Gatzemeier, J von Pawel, M Gottfried, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancerA B Sandler, J Nemunaitis, C Denham, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 23, 1999
Concomitant chemotherapy and IFN-alpha for small cell lung cancer: a randomized multicenter phase III studyT M Ruotsalainen, M Halme, K Tamminen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II studyU Gatzemeier, F A Shepherd, T Le Chevalier, et al.
Bulletin Du Cancer|March 1, 1997
[A phase II multicenter study of gemcitabine in non small cell lung cancers]T Le Chevalier, M Gottfried, U Gatzemeier, et al.
Pageof 19